雪榕生物(300511) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 436,980,006.96, down 12.32% year-on-year, while year-to-date revenue was CNY 1,320,164,143.02, an increase of 1.11%[7] - Net profit attributable to shareholders was a loss of CNY 5,630,980.76, a decline of 105.49% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of CNY 7,520,413.16, a decrease of 111.63% year-on-year[7] - The basic earnings per share for the reporting period was -CNY 0.01, a decrease of 104.17% compared to the same period last year[7] - The weighted average return on equity was -0.34%, down 7.31% from the previous year[7] - Total operating revenue for the current period is $436.98 million, down from $498.41 million in the previous period, representing a decrease of approximately 12.3%[39] - Total operating costs increased to $449.61 million from $436.03 million, marking an increase of about 3.9%[39] - Operating profit for the current period is -$10.77 million, a significant decline from $106.44 million in the previous period[40] - Net profit for the current period is -$9.57 million, compared to a net profit of $99.44 million in the previous period, indicating a substantial decrease[40] - Basic and diluted earnings per share for the current period are both -$0.01, down from $0.24 in the previous period[41] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 354,476,940.78, an increase of 36.89%[7] - The company's cash flow from operating activities increased by 36.89% to ¥354,476,940.78 compared to the same period last year[18] - The net cash flow from operating activities for Q3 2019 was CNY 354,476,940.78, an increase of 37% compared to CNY 258,958,644.37 in Q3 2018[56] - Total cash inflow from operating activities was CNY 1,403,022,840.62, while cash outflow was CNY 1,048,545,899.84, resulting in a net cash inflow of CNY 354,476,940.78[56] - The cash flow from investment activities showed a net outflow of CNY 100,966,049.77, compared to a net outflow of CNY 166,158,737.17 in the previous year[57] - Cash inflow from financing activities totaled CNY 690,834,067.00, while cash outflow was CNY 1,039,243,966.16, leading to a net cash outflow of CNY 348,409,899.16[57] - The company experienced a net cash flow decrease of CNY 93,684,037.21 in Q3 2019 compared to a decrease of CNY 31,439,811.00 in Q3 2018[57] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,705,301,564.59, a decrease of 4.81% compared to the end of the previous year[7] - Total assets decreased from CNY 3,892,502,755.55 to CNY 3,705,301,564.59, a decline of approximately 4.8%[30] - Current liabilities decreased from CNY 1,393,206,826.21 to CNY 1,252,486,848.21, a reduction of about 10.1%[31] - Long-term borrowings decreased from CNY 776,194,980.00 to CNY 737,841,034.80, a decrease of approximately 4.9%[31] - Total liabilities decreased from CNY 2,322,561,697.27 to CNY 2,085,226,813.46, a decline of around 10.2%[31] - Owner's equity increased from CNY 1,569,941,058.28 to CNY 1,620,074,751.13, an increase of about 3.2%[32] - Cash and cash equivalents decreased from CNY 202,185,795.02 to CNY 102,111,160.64, a decline of approximately 49.6%[34] - Accounts receivable increased from CNY 13,900,233.43 to CNY 17,696,897.21, an increase of about 27.0%[34] - Inventory increased slightly from CNY 13,245,128.23 to CNY 14,320,437.44, an increase of approximately 8.1%[34] - The total current assets decreased from CNY 1,350,138,896.60 to CNY 1,103,900,994.60, a decline of about 18.3%[35] - Non-current assets increased slightly from CNY 1,031,536,937.28 to CNY 1,033,306,029.18, an increase of approximately 0.2%[35] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 22,344[11] - The largest shareholder, Yang Yongping, held 31.00% of the shares, totaling 133,085,500 shares[11] Other Financial Metrics - The company reported a government subsidy of CNY 20,714,013.66, primarily related to relocation compensation[8] - Asset impairment losses rose by 64.01% to ¥586,709.92, primarily due to the reversal of inventory write-downs[18] - The company did not implement any cash dividend plan during the third quarter of 2019[22] - The company reported an investment income of $15 million for the current period, with no corresponding figure in the previous period[43] - Other comprehensive income after tax for the current period is $2.17 million, down from $2.61 million in the previous period[41] - The total comprehensive income for the current period is -$7.40 million, a stark contrast to $102.05 million in the previous period[41] - The total comprehensive income for the period was ¥108,200,483.86, compared to ¥123,422,723.02, a decline of 12.3%[49]